DelMar Pharmaceuticals Inc (OTCBB:DMPI) Slides on Record-Breaking Volume
Back in July, Zacks Small-Cap Research initiated a coverage on DelMar Pharmaceuticals Inc (OTCBB:DMPI) and put a price target for the next twelve months of $4.50. Now, less than six months later, this seems...